z-logo
open-access-imgOpen Access
Risk Factors Associated With Faster Time to Vancomycin-Resistant Enterococci Positivity in Acute Myeloid Leukemia Patients Undergoing Initial Intensive Induction Chemotherapy With Cytarabine and Idarubicin
Author(s) -
Ronald Heisel,
Robert M Sutton,
Gerard P. Mascara,
Daniel G. Winger,
Seah H. Lim,
David R. Weber,
LouiseMarie Oleksiuk
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw172.154
Subject(s) - idarubicin , medicine , cytarabine , vancomycin , induction chemotherapy , myeloid leukemia , chemotherapy , oncology , staphylococcus aureus , biology , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom